Published in Cancer on February 01, 1978
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). Leuk Lymphoma (2012) 1.49
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol (2013) 1.34
The spectrum of coincident entities with small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) diagnosed by cytology. Cytojournal (2010) 0.77
Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature. Mol Clin Oncol (2016) 0.75
Clonal analysis of three morphologically distinct lymphomas occurring in the same patient. J Clin Pathol (1994) 0.75
Induction of maturation of human B-cell lymphomas in vitro. Morphologic changes in relation to immunoglobulin and DNA synthesis. Am J Pathol (1984) 0.75
Chest Wall Swelling, A Rare Presentation of Richter's Transformation. Indian J Hematol Blood Transfus (2010) 0.75
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (1998) 3.21
Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Res (1992) 2.92
The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol (1999) 2.40
Mantle cell lymphoma-- an entity comes of age. Blood (1996) 2.30
Superficial bladder cancer: progression and recurrence. J Urol (1983) 2.30
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol (2002) 2.28
Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. J Clin Oncol (1993) 2.00
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med (1987) 1.98
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. J Clin Oncol (1991) 1.94
International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol (1999) 1.76
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol (1993) 1.69
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol (1993) 1.66
Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med (1989) 1.62
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.58
Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. Blood (1987) 1.56
F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma (2007) 1.54
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol (1996) 1.53
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med (1972) 1.49
Clinical applications of hematopoietic growth factors. J Clin Oncol (1995) 1.47
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. Leuk Lymphoma (1998) 1.39
Allogeneic bone marrow transplantation: problems and prospects. Mayo Clin Proc (1992) 1.39
Howell-Jolly body-like inclusions in the neutrophils of patients with acquired immunodeficiency syndrome. Am J Clin Pathol (1994) 1.38
Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group. J Clin Oncol (1990) 1.37
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood (1992) 1.36
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (2001) 1.34
Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29
Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst (2001) 1.26
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group. Am J Hematol (2000) 1.26
Involvement of the central nervous system in non-Hodgkin's lymphoma. Cancer (1975) 1.24
Splenic rupture in patients with hematologic malignancies. Cancer (1981) 1.22
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol (1996) 1.22
The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood (1991) 1.20
Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer (1979) 1.16
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16
Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol (1999) 1.13
The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1988) 1.11
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant (1998) 1.10
Towards understanding the peripheral T-cell lymphomas. Ann Oncol (2004) 1.09
Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue. Am J Pathol (1987) 1.09
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol (2002) 1.09
High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood (1989) 1.09
High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol (1997) 1.07
Hematopoietic growth factors. CA Cancer J Clin (1996) 1.07
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Biol Blood Marrow Transplant (2000) 1.06
Evolution of the French-American-British (FAB) proposals. Is there a place for acute basophilic leukemia? Am J Clin Pathol (1991) 1.06
Typhlitis in acute leukemia: successful treatment by early surgical intervention. Cancer (1979) 1.05
Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol (1999) 1.05
Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age. J Am Geriatr Soc (1984) 1.05
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol (1989) 1.04
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma. Biol Blood Marrow Transplant (2001) 1.04
Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer (1985) 1.04
Fournier's gangrene complicating aggressive therapy for hematologic malignancy. Cancer (1986) 1.03
Clinical and prognostic significance of bone marrow involvement in patients with diffuse aggressive B-cell lymphoma. J Clin Oncol (1995) 1.03
Hair dye use and risk of leukemia and lymphoma. Am J Public Health (1988) 1.03
Diagnostic concurrence in the subclassification of adult acute leukemia using French-American-British criteria. Cancer (1982) 1.02
Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (1999) 1.02
Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood (1988) 1.01
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. Ann Intern Med (1986) 1.00
Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen. J Clin Oncol (1984) 1.00
Feasibility of semen cryopreservation in patients with malignant disease. JAMA (1980) 0.99
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood (2000) 0.99
Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. Arch Intern Med (1973) 0.99
Hypoplastic acute leukemia. Cancer (1981) 0.98
Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters. Bone Marrow Transplant (1991) 0.98
Lymphoma classification--the gap between biology and clinical management is closing. Blood (1996) 0.98
The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project. Ann Oncol (2009) 0.97
Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood (1995) 0.97
Antitumour effect of cimetidine. Lancet (1979) 0.97
High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients. Ann Oncol (1993) 0.96
Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol (1986) 0.95
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study. Cancer (1983) 0.94
High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Ann Oncol (1996) 0.94
Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood (1989) 0.94
Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. J Clin Oncol (1986) 0.93
Phytohemagglutinin-induced lymphocyte transformation: the relationship to prognosis of Hodgkin's disease. Blood (1972) 0.93
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Bone Marrow Transplant (2000) 0.92
Immunofluorescent skin test in systemic lupus erythematosus. Lack of relationship with renal disease. JAMA (1972) 0.92
Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. Ann Oncol (2006) 0.92
Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia. Am J Clin Pathol (1994) 0.92
The lymph node in chronic lymphocytic leukemia. Cancer (1978) 0.91
High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. Ann Oncol (1998) 0.90
Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. Cancer Genet Cytogenet (1999) 0.90
Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. Hematol Oncol (1987) 0.90
Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer (1992) 0.90
Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res (1988) 0.89
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant (1989) 0.89
Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy. Bone Marrow Transplant (1991) 0.88
Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. Arch Intern Med (1983) 0.88
Myeloid metaplasia and osteolytic lesions. Am J Clin Pathol (1978) 0.88
Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer (1990) 0.88